Cargando…
Changes in inflammatory cytokine networks in myasthenia gravis
Myasthenia gravis (MG) is an autoimmunological inflammatory disorder of the neuromuscular junction. Inflammation could be a key player for understanding the pathogenesis of MG. We measured the serum levels of 24 inflammatory cytokines in 43 patients with anti-acetylcholine receptor antibody-positive...
Autores principales: | Uzawa, Akiyuki, Kanai, Tetsuya, Kawaguchi, Naoki, Oda, Fumiko, Himuro, Keiichi, Kuwabara, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865732/ https://www.ncbi.nlm.nih.gov/pubmed/27172995 http://dx.doi.org/10.1038/srep25886 |
Ejemplares similares
-
Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease
por: Yamamoto, Yohei, et al.
Publicado: (2021) -
Response to treatment of myasthenia gravis according to clinical subtype
por: Akaishi, Tetsuya, et al.
Publicado: (2016) -
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis
por: Oyama, Munenori, et al.
Publicado: (2020) -
Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study
por: Nagane, Yuriko, et al.
Publicado: (2017) -
Reappraisal of Oral Steroid Therapy for Myasthenia Gravis
por: Imai, Tomihiro, et al.
Publicado: (2020)